SCCS Finalizes Safety Opinion on Cosmetic Acetophenone

The European committee assessment follows an ECHA classification warning of reproductive toxicity for the perfuming agent.

Updated on Oct. 15, 2026 in Chemistry

Isometric editorial illustration showing a geometric chemical lattice structure representing the molecular safety analysis of acetophenone.
The Scientific Committee on Consumer Safety has finalized its regulatory opinion regarding the use of acetophenone in cosmetic products. AI Illustration. Upload story photo >

Live Poll

Do you trust the safety assessments conducted by government committees for ingredients in your cosmetic products?

The Scientific Committee on Consumer Safety (SCCS) has published its final opinion on the safety of acetophenone, a common perfuming agent in cosmetics. This assessment follows a 2025 recommendation to classify the substance as a Reprotoxic Category 1B compound.

Why it matters

The review stems from a mandate by the European Commission after the European Chemicals Agency identified potential reproductive toxicity concerns. This regulatory process is critical for manufacturers evaluating the inclusion of acetophenone as a constituent in natural complex substances.

Acetophenone (CAS 98-86-2, EC 202-708-7) is assessed for use as a perfuming agent at concentrations up to 100 ppm. The evaluation follows a March 2025 ECHA recommendation to label the compound as Reprotoxic Category 1B, indicating evidence of reproductive toxicity.

The players

Scientific Committee on Consumer Safety (SCCS)

An independent EU advisory body that provides expert scientific advice on health and safety risks related to consumer products.

European Chemicals Agency (ECHA)

The EU agency managing the technical and scientific aspects of the implementation of European chemicals legislation.

The details

The SCCS evaluated a dossier submitted by industry stakeholders to defend the chemical's use within natural complex substances. The committee reviewed evidence and public commentary collected between April 30 and July 6, 2026, to determine if these specific concentrations pose a risk to human health. The process specifically examines acetophenone, an aromatic compound, in the context of its classification as a reproductive hazard.

Timeline

  1. March 2025: ECHA RAC recommended Reprotoxic Category 1B classification.

  2. September 2025: Industry informed the Commission of its safety defense.

  3. April 30, 2026: Public commenting period opened.

  4. May 2026: SCCS published its preliminary opinion.

  5. July 6, 2026: Public commenting period closed.

The Tech Race

The SCCS assessment represents a critical step in reconciling industry use of aromatic compounds with stringent EU reproductive toxicity standards. It follows the precedent established by the ECHA's 2025 classification, which sets the benchmark for safety requirements in cosmetic formulations.

Cosmetic manufacturers using acetophenone must track the European Commission's pending regulatory response to determine if current formulas remain compliant. Until the Commission acts, the potential for restricted concentrations or labels remains a primary consideration for product development.

The takeaway

The SCCS opinion formalizes the scrutiny of acetophenone in cosmetic applications following reclassification as a reproductive hazard. Industry stakeholders should monitor the European Commission for upcoming legislative decisions that will dictate the allowed usage thresholds.

Further reading

For broader trends in chemical safety and regulation, see the latest research in /science/chemistry/.

Live Poll

Do you trust the safety assessments conducted by government committees for ingredients in your cosmetic products?